XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2020   10,950,289    
Balance at beginning of period at Dec. 31, 2020 $ 223,726 $ 65,395 $ 158,359 $ (28)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 26,723   26,723  
Net unrealized loss on securities available for sale, net of tax (5,636)     (5,636)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 34     34
Net unrealized gain on cash flow hedging derivative instruments, net of tax 3,395     3,395
Comprehensive income (loss) 24,516   26,723 (2,207)
Cash dividends declared (10,438)   (10,438)  
Equity compensation expense 672 $ 672    
Payment to repurchase common stock (in shares)   (10,252)    
Payment to repurchase common stock (253)   (253)  
Issuance of restricted stock (in shares)   34,689    
Proceeds from sale of common stock (in shares)   18,224    
Proceeds from sale of common stock $ 514 $ 514    
Ending balance (in shares) at Sep. 30, 2021 10,992,950 10,992,950    
Balance at end of period at Sep. 30, 2021 $ 238,737 $ 66,581 174,391 (2,235)
Beginning balance (in shares) at Jun. 30, 2021   10,987,680    
Balance at beginning of period at Jun. 30, 2021 234,155 $ 66,225 168,908 (978)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 9,014   9,014  
Net unrealized loss on securities available for sale, net of tax (1,817)     (1,817)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 14     14
Net unrealized gain on cash flow hedging derivative instruments, net of tax 546     546
Comprehensive income (loss) 7,757   9,014 (1,257)
Cash dividends declared (3,518)   (3,518)  
Equity compensation expense 183 $ 183    
Payment to repurchase common stock (in shares)   (691)    
Payment to repurchase common stock (13)   (13)  
Proceeds from sale of common stock (in shares)   5,961    
Proceeds from sale of common stock $ 173 $ 173    
Ending balance (in shares) at Sep. 30, 2021 10,992,950 10,992,950    
Balance at end of period at Sep. 30, 2021 $ 238,737 $ 66,581 174,391 (2,235)
Beginning balance (in shares) at Dec. 31, 2021 10,998,765 10,998,765    
Balance at beginning of period at Dec. 31, 2021 $ 245,657 $ 66,940 180,417 (1,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 29,793   29,793  
Net unrealized loss on securities available for sale, net of tax (45,943)     (45,943)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 20     20
Net unrealized gain on cash flow hedging derivative instruments, net of tax 500     500
Comprehensive income (loss) (15,630)   29,793 (45,423)
Cash dividends declared (11,032)   (11,032)  
Equity compensation expense 610 $ 610    
Payment to repurchase common stock (in shares)   (8,640)    
Payment to repurchase common stock (276)   (276)  
Issuance of restricted stock (in shares)   28,745    
Proceeds from sale of common stock (in shares)   19,354    
Proceeds from sale of common stock $ 588 $ 588    
Ending balance (in shares) at Sep. 30, 2022 11,038,224 11,038,224    
Balance at end of period at Sep. 30, 2022 $ 219,917 $ 68,138 198,902 (47,123)
Beginning balance (in shares) at Jun. 30, 2022   11,030,236    
Balance at beginning of period at Jun. 30, 2022 227,685 $ 67,737 192,565 (32,617)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 10,091   10,091  
Net unrealized loss on securities available for sale, net of tax (14,866)     (14,866)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 6     6
Net unrealized gain on cash flow hedging derivative instruments, net of tax 354     354
Comprehensive income (loss) (4,415)   10,091 (14,506)
Cash dividends declared (3,754)   (3,754)  
Equity compensation expense 198 $ 198    
Issuance of restricted stock (in shares)   1,250    
Proceeds from sale of common stock (in shares)   6,738    
Proceeds from sale of common stock $ 203 $ 203    
Ending balance (in shares) at Sep. 30, 2022 11,038,224 11,038,224    
Balance at end of period at Sep. 30, 2022 $ 219,917 $ 68,138 $ 198,902 $ (47,123)